赛帕利单抗

Records for this ingredient, by country (identity only).

ATC L01XC · 1 markets · 1 records

赛帕利单抗 1 markets · 1 records Forms
Filters
MarketCN 1

CN 1 records · 1 shown of 1 Source 国家医保局 医保药品分类与代码数据库 · Data as of 2025-04-04

  • 120 mg per mL / per unit basis not statedinjection誉妥赛帕利单抗

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.